What we do
We broker and finance agreements – which otherwise wouldn’t be made – to bring medical innovations to more people, in more countries, as quickly as possible.
We increase access to medical innovations
Our agreements accelerate access to health products that can save and protect lives.
We analyse markets across a range of health areas, identifying opportunities to increase access to products in countries where they are unavailable or unaffordable.
Many of the products we support are newly developed. In the past, it has taken years – or even decades – for medical innovations to reach people in Africa and Asia.
We negotiate agreements with manufacturers and procurers to get more products into the hands of more people more quickly.
“It’s been a great partnership with MedAccess. They brought to the table experience and access to influential institutions and individuals in the region that we would otherwise not have had access to.”
Jesse Wambugu, Director, Global Access Initiative in Africa, Hologic
We bring innovative financial solutions
We use our innovative finance products to accelerate access to medical innovations. Our $200 million capital, provided by British International Investment, enables us to make agreements that impact the lives of millions of people.
We recognise that complex global health challenges often require bespoke solutions. We tailor our agreements so that they meet the needs of all partners, whilst staying focused on our three impact indicators – changing lives, saving money and shaping markets.
“We benefitted from the experience MedAccess had using volume guarantees so we could build on that and translate it into our public health environment.”
Achim Reddig, Director of Global Public Health, BASF
We work in partnership
We work with governments, businesses, global health organisations, and civil society, to get life-changing products to the people who need them.
All partners play an important role. We work closely with each partner to understand their expertise, priorities and capacity, and how we can structure our agreement to ensure we achieve the maximum impact together.
Above all, we recognise that no single organisation can solve global health challenges alone. We are committed to working with partners who share our ambition for greater health equity.
We are part of a global effort
We are playing our part in global efforts to achieve the United Nations Sustainable Development Goals (SDGs). We specifically contribute to:
- Goal 3 – Ensure healthy lives and promote well-being for all ages
- Goal 5 – Achieve gender equality and empower all women and girls
- Goal 10 – Reduce inequality within and among countries
- Goal 17 – Strengthen the means of implementation and revitalise the global partnership for sustainable development
We are working with our partners to help the world get back on track after COVID-19 and accelerate efforts to achieve the SDGs by 2030.
Our sustainable business model
We are motivated by purpose, not profit. Any operational surpluses are invested back into the organisation so that we can secure more agreements to accelerate access to for medical innovations.
Our business model is designed to ensure we achieve the maximum impact while keeping operational costs low. We take a blended finance approach. This means we can use grants and investment capital to enable us to make and finance agreements.
We accept grant funding to cover the costs of scoping, negotiating and executing financing agreements. Since 2021, the UK’s Foreign, Commonwealth & Development Office has provided us with £17 million in grant funding as part of its Global Fund Accelerator grants.
We also charge a fee for access to our financial tools. This income is used to cover the costs of the partnership, such as implementation and monitoring.
Our values
We are mission-driven
We are humble
We are relentless about rigour
We build trust
